We are live on ! Find out more
PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

90 hedge funds and large institutions have $245M invested in Paratek Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

560% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 5

443% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 7

57% more call options, than puts

Call options by funds: $2.08M | Put options by funds: $1.33M

45% more funds holding

Funds holding: 62 → 90 (+28)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

15% more capital invested

Capital invested by funds: $213M → $245M (+$31.2M)

Holders
90
Holders Change
+28
Holders Change %
+45.16%
% of All Funds
2.4%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
33
Increased
38
Reduced
7
Closed
5
Calls
$2.08M
Puts
$1.33M
Net Calls
+$752K
Net Calls Change
+$470K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$8.47M
2
BG
Baupost Group
Massachusetts
+$7.36M
3
OFM
Omega Fund Management
Massachusetts
+$6.79M
4
NI
Numeric Investors
Massachusetts
+$4.59M
5
BC
Broadfin Capital
New York
+$4.02M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.32M
2
GPP
Great Point Partners
Connecticut
-$4.07M
3
JP Morgan Chase
JP Morgan Chase
New York
-$3.29M
4
AC
Aisling Capital
New York
-$2.94M
5
NMC
NEA Management Company
Maryland
-$865K
Name Holding Trade Value Shares
Change 		Change in
Stake
OFM
1
Omega Fund Management
Massachusetts
$36.2M +$6.79M +461,538 +22%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$29.4M -$7.32M -497,441 -19%
BG
3
Baupost Group
Massachusetts
$28.4M +$7.36M +500,000 +32%
A
4
Abingworth
United Kingdom
$18.1M – – –
BC
5
Broadfin Capital
New York
$11.2M +$4.02M +273,050 +51%
TCM
6
Tekla Capital Management
Massachusetts
$10.6M – – –
BI
7
BVF Inc
California
$8M +$8.47M +575,000 New
AC
8
Aisling Capital
New York
$6.71M -$2.94M -200,000 -29%
GAI
9
General American Investors
New York
$6.64M +$2.94M +200,000 +72%
FIG
10
Fortress Investment Group
New York
$6.03M – – –
Vanguard Group
11
Vanguard Group
Pennsylvania
$5.95M +$941K +63,885 +18%
RSCM
12
Rock Springs Capital Management
Maryland
$5.82M +$2.88M +195,500 +88%
BFA
13
BlackRock Fund Advisors
California
$5.19M +$823K +55,915 +18%
BBHC
14
Brown Brothers Harriman & Co
New York
$5.12M – – –
GIM
15
Granahan Investment Management
Massachusetts
$4.88M +$441K +29,930 +9%
NI
16
Numeric Investors
Massachusetts
$4.33M +$4.59M +311,655 New
SM
17
Sabby Management
Florida
$4.26M +$1.67M +113,642 +59%
RAM
18
Roumell Asset Management
Maryland
$4.04M +$1.07M +73,008 +34%
LOAMU
19
Lombard Odier Asset Management (USA)
New York
$2.78M +$1.63M +110,469 +123%
Northern Trust
20
Northern Trust
Illinois
$2.41M +$517K +35,108 +25%
Millennium Management
21
Millennium Management
New York
$2.38M +$2.52M +171,229 New
State Street
22
State Street
Massachusetts
$2.23M +$7.16K +486 +0.3%
OM
23
Opaleye Management
Massachusetts
$2.04M +$2.16M +146,700 New
BIT
24
BlackRock Institutional Trust
California
$1.96M +$168K +11,443 +9%
SFM
25
Sphera Funds Management
Israel
$1.95M +$2.06M +140,000 New
1
2 3 4

PRTK Hedge Fund Activity: Q2 2016 in Review

90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q2 2016, worth a combined $245M — up 15% from $213M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new PRTK positions and 5 closed out — a net gain of 28 holders — while 38 added to existing stakes and 7 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $8.47M. The largest seller was Fidelity Investments, cutting an estimated $7.32M.

  • 90 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q2 2016, up from 62 in Q1 2016.
  • Funds reported $245M of Paratek Pharmaceuticals, Inc. stock for Q2 2016, up 15% quarter-over-quarter.
  • 33 funds opened new Paratek Pharmaceuticals, Inc. positions in Q2 2016 and 5 closed out, a net change of +28 holders.
  • The largest Paratek Pharmaceuticals, Inc. buyer in Q2 2016 was BVF Inc, an estimated $8.47M added.
  • The largest Paratek Pharmaceuticals, Inc. seller in Q2 2016 was Fidelity Investments, an estimated $7.32M sold.

Based on aggregated 13F filings for Q2 2016.